Target Company Overview
Karell Kiirabi, based in Estonia, is the country’s first private ambulance service provider. Established to enhance emergency medical services, the company operates a fleet of 18 units and employs over 300 professionals, serving the regions of North and North-East Estonia. Throughout its trajectory, Karell Kiirabi has significantly upgraded its operations, including modernizing its ambulance fleet and stations, leading to substantial business growth.
Since BaltCap Growth Fund (BGF) invested in Karell Kiirabi in 2019, the company has experienced remarkable developments. Under the leadership of Co-CEOs Õnne Bartoševitš and Ivetta Sakkart, Karell Kiirabi has demonstrated a 50% increase in revenue during the holding period, indicating its robust operational expansion and strengthening management team.
Industry Overview in Estonia
The ambulance services industry in Estonia has seen critical advancements in recent years, particularly with the advent of private sector participation like Karell Kiirabi. Traditionally, the Estonian emergency medical service was predominantly public, but the rise of private providers has introduced competition, driving improvements in service quality as providers innovate and adopt new technologies.
Moreover, the COVID-19 pandemic acted as a catalyst for the industry, with providers such as Karell Kiirabi pioneering modern solutions like smart fleet management and automated disinfection systems. Such innovations are essential not only for maintaining high service standards during crises but also for setting new industry benchmarks.
As technology continues to influence the healthcare landscape, Estonian ambulance services are beginning to integrate telemedicine and eAmbulance solutions. These developments promise to enhance the efficiency and effectiveness of emergency responses, ultimately leading to better patient outcomes.
Furthermore, the commitment of private companies to maintaining high-quality service without compromising on standards plays a vital role in advancing the entire medical response system in Estonia. It is crucial for stakeholders in this sector to adapt rapidly to ongoing changes to remain competitive and continue delivering exemplary care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
The divestment of Karell Kiirabi by BGF’s portfolio company Pihlakodu is strategically aligned with the goal of allowing Pihlakodu to concentrate on its core business of elderly care services. By transitioning ownership to Südamekodud, an established local elderly care chain, Karell Kiirabi will benefit from enhanced focus and resources to pursue further growth opportunities.
This transaction not only underscores BGF's commitment to fostering growth in its portfolio companies but also enables the reallocation of efforts to prioritize the burgeoning elderly care sector in Estonia, which is increasingly important given the aging population and evolving healthcare needs.
Information About the Investor
BaltCap Growth Fund (BGF) is a leading investment firm specializing in private equity within the Baltic region. Focused on supporting the growth of innovative companies across various sectors, BGF invests strategically in businesses that demonstrate high potential for expansion and profitability. Throughout its tenure, BGF has successfully managed multiple portfolio companies, providing them with the necessary capital and expertise to enhance operational efficacy and market standing.
Through its investment in Karell Kiirabi, BGF has established itself as a vital contributor to the evolution of emergency medical services in Estonia. Their commitment to modernizing healthcare infrastructure and improving industry standards aligns with their long-term vision of facilitating sustainable growth in the region.
View of Dealert
The divestment of Karell Kiirabi presents a mixed perspective on investment value. On one hand, the 50% revenue growth during BGF’s holding period is a notable indicator of the company’s potential for continued success, particularly with its proactive embrace of modern technologies such as telemedicine solutions. This trend suggests that Karell Kiirabi is well-positioned to capitalize on industry changes and consumer demands moving forward.
On the other hand, the transition of ownership to a company focusing on elderly care may raise questions regarding the strategic continuity of Karell Kiirabi's ambitious expansion plans. Ensuring that the new leadership maintains the commitment to growth and innovation will be critical for sustaining service quality and operational momentum.
Furthermore, as the Estonian emergency medical services sector is undergoing significant changes, Karell Kiirabi's ability to integrate new technologies and adapt to evolving market needs will determine its future viability. The new owners, emphasizing the importance of maintaining local capital and high service standards, could foster a beneficial environment for ongoing progress in the industry.
In conclusion, while the deal offers potential for both parties involved, it will be essential for the new ownership of Karell Kiirabi to balance their existing commitments with the demands of a rapidly evolving healthcare landscape to ensure that investment in this transition yields positive long-term outcomes.
Similar Deals
TPG Asia → Sai Life Sciences Private Limited
2025
StepStone Group → dss+ and Essential Pharma
2024
Hidayat family → PT Industri Jamu dan Farmasi Sido Muncul Tbk
2024
Tail End Capital → MedSpa Partners, Inc.
2024
Webster Capital → MedMark Services
2023
York Capital Management → Healthcare Linen Services Group
2023
Court Square Capital Partners → National Seating & Mobility
2023
Südamekodud
invested in
Karell Kiirabi
in 2023
in a Secondary Buyout deal